Knockdown of STAT1 could not only inhibit prostate cancer development in vitro, but also diminish the promotion effects induced by CDKL3 overexpression, highlighting the critical role of STAT1 as the mediator. This evidence concerns the gene CDKL3 and prostate carcinoma.